Adrenergic alpha-Antagonists

All categories
DBCAT000696Therapeutic categoryG04CA

Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and... A DrugBank category of 78 drugs. 62 of them are approved.

ATC classification
Part of
Adrenergic Antagonists
Also known as
Adrenergic alpha Antagonists · Adrenergic alpha Blockers · Adrenergic alpha Receptor Blockaders · Adrenergic alpha-Blockers · Adrenergic alpha-Receptor Blockaders
Drugs

and 53 more with a free account

What you can answer from here — as of August 12, 2019

78DrugsEach linked to its full drug card
Sign in
154Drug targetsEvery drug–target pair in the class, with bond type
Sign in
27,678Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
16Routes of administrationHow the drugs in this class are given
Sign in
2SubcategoriesNarrower classes within this one
Sign in

Which targets do Adrenergic alpha-Antagonists share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In